|
|
||||||||
1From the Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky; and the 2Department of Ophthalmology, Columbia University, New York, New York.
PURPOSE. There is increasing evidence that the complement system may play a significant role in one of the leading diseases causing blindness in the elderly population, age-related macular degeneration. In this study, a novel role in the retina for a regulatory protein in the complement system, CD46, is proposed.
METHODS. The retinal pigment epithelium (RPE) was obtained from human donor eyes as well as human immortalized RPE cell lines (ARPE19). Immunohistochemistry and confocal microscopy were used to immunolocalize CD46 and ß1 integrin. Immunoprecipitation experiments with antibodies to either CD46 or ß1 integrin were performed on RPE cell lysates. A cell adhesion assay was used to determine the proportion of RPE cells that adhere to Bruchs membrane explants from donor eyes.
RESULTS. Immunohistochemistry and confocal microscopy demonstrated that CD46 was polarized to the basal surface of the RPE along with ß1 integrin, shown previously to be involved in RPE adhesion. Immunoprecipitation experiments demonstrated that CD46 and ß1 integrin coprecipitated from RPE cell lysates when either protein was used as the precipitating antibody. The adhesion assay showed that antibodies to either CD46 or ß1 integrin reduced RPE adhesion to the surface of Bruchs membrane compared with the control.
CONCLUSIONS. These findings suggest that this complement regulatory protein, which protects host cells from autologous complement attack, may have a functional interaction with ß1 integrin in the eye that is related to RPE adhesion to its basement membrane and Bruchs membrane.
This article has been cited by other articles:
![]() |
C. J. Fang, V. Fremeaux-Bacchi, M. K. Liszewski, G. Pianetti, M. Noris, T. H. J. Goodship, and J. P. Atkinson Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome Blood, January 15, 2008; 111(2): 624 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tuo, C. M. Bojanowski, M. Zhou, D. Shen, R. J. Ross, K. I. Rosenberg, D. J. Cameron, C. Yin, J. A. Kowalak, Z. Zhuang, et al. Murine Ccl2/Cx3cr1 Deficiency Results in Retinal Lesions Mimicking Human Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3827 - 3836. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Mullins, M. H. Kuehn, E. A. Faidley, N. A. Syed, and E. M. Stone Differential Macular and Peripheral Expression of Bestrophin in Human Eyes and Its Implication for Best Disease Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3372 - 3380. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Mallam, M. Y. Hurwitz, T. Mahoney, P. Chevez-Barrios, and R. L. Hurwitz Efficient Gene Transfer into Retinal Cells Using Adenoviral Vectors: Dependence on Receptor Expression Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1680 - 1687. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |